REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/17/2025
Back to search
Official data from USPTO
NEULYFEL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
03/17/2025
Trademark type
Word
Nice classes
5, 44
Filing date
02/22/2019
Registration date
03/17/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/17/2020
Last transaction
03/17/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
27
Owner location
CH
Examiner
CIANCI, RYAN
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Iovance Biotherapeutics GmbH
Representatives
Carla B. Oakley Morgan, Lewis & Bockius LLP
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and biological preparations for the treatment of immune system related and oncological diseases and disorders; diagnostic preparations for medical usebiological diagnostic preparations for medical use
Class 44
Medical servicesmodification of cells for the treatment of cancer and other diseases and medical conditions; immunotherapy treatments; medical diagnosis and treatment of immune system related diseases and disorders; providing information relating to oncology and immunotherapy treatment; provision of medical information and medical consultant services; collection and preservation of biological tissue
Publications
History of USPTO decisions and trademark events.
27 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/25/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/01/2020
FIMP
FINAL DISPOSITION PROCESSED
08/01/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/17/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
03/17/2020
GPNX
NOTIFICATION PROCESSED BY IB
01/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/31/2019
PUBO
PUBLISHED FOR OPPOSITION
12/31/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/18/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/18/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/11/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/25/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/18/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/18/2019
ALIE
ASSIGNED TO LIE
11/18/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/13/2019
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
10/04/2019
RFNT
REFUSAL PROCESSED BY IB
06/21/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/03/2019
RFRR
REFUSAL PROCESSED BY MPU
06/03/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/15/2019
CNRT
NON-FINAL ACTION WRITTEN
05/14/2019
DOCK
ASSIGNED TO EXAMINER
05/02/2019
MAFR
APPLICATION FILING RECEIPT MAILED
04/02/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/27/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/21/2019
Continuous trademark protection
Get notified about every new filing that threatens NEULYFEL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.